id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-P-6044-0006,FDA,FDA-2019-P-6044,Agency Response Letter from FDA CDER to Latham and Watkins LLP,Other,Agency Response,2020-04-24T04:00:00Z,2020,4,2020-04-24T04:00:00Z,,2020-04-24T17:23:38Z,,0,0,09000064844d3255